Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer (ACHILES)
A Randomized Phase II Study Comparing Atezolizumab After Concurrent Chemo-radiotherapy With Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer
Sponsor: Aalborg University Hospital
This PHASE2 trial investigates Small-cell Lung Cancer and is currently ongoing. Aalborg University Hospital leads this study, which shows 24 recorded versions since 2018 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
24 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting PHASE2
-
Mar 2025 — Sep 2025 [monthly]
Active Not Recruiting PHASE2
-
Feb 2025 — Mar 2025 [monthly]
Active Not Recruiting PHASE2
-
Sep 2024 — Feb 2025 [monthly]
Active Not Recruiting PHASE2
-
Aug 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE2
▶ Show 19 earlier versions
-
Jul 2024 — Aug 2024 [monthly]
Active Not Recruiting PHASE2
-
Feb 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE2
-
Jul 2023 — Feb 2024 [monthly]
Active Not Recruiting PHASE2
-
Jun 2023 — Jul 2023 [monthly]
Active Not Recruiting PHASE2
-
Jun 2022 — Jun 2023 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Jan 2022 — Jun 2022 [monthly]
Recruiting PHASE2
-
Jan 2021 — Jan 2022 [monthly]
Recruiting PHASE2
-
Jul 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Jun 2020 — Jul 2020 [monthly]
Recruiting PHASE2
-
Apr 2020 — Jun 2020 [monthly]
Recruiting PHASE2
-
Oct 2019 — Apr 2020 [monthly]
Recruiting PHASE2
-
Jul 2019 — Oct 2019 [monthly]
Recruiting PHASE2
-
Jun 2019 — Jul 2019 [monthly]
Recruiting PHASE2
-
May 2019 — Jun 2019 [monthly]
Recruiting PHASE2
-
Dec 2018 — May 2019 [monthly]
Recruiting PHASE2
-
Nov 2018 — Dec 2018 [monthly]
Recruiting PHASE2
-
Oct 2018 — Nov 2018 [monthly]
Recruiting PHASE2
-
Sep 2018 — Oct 2018 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Aalborg University Hospital
- Alesund Hospital
- Amphia Hospital
- Cantonal Hospital of St. Gallen
- Ente Ospedaliero Cantonale, Bellinzona
- Erasmus Medical Center
- Freiburger Spital
- Gävle Hospital
- Haukeland University Hospital
- Helse Fonna
- Helse Nord-Trøndelag HF
- Helse Stavanger HF
- Insel Gruppe AG, University Hospital Bern
- Isala
- Kantonsspital Graubünden
- Kantonsspital Olten
- Kantonsspital Winterthur KSW
- Karolinska University Hospital
- Klinik Hirslanden, Zurich
- Kristiansund Hospital
- Medisch Spectrum Twente
- Molde Hospital
- National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos
- Nordlandssykehuset HF
- Norwegian University of Science and Technology
- Odense University Hospital
- Oslo University Hospital
- Rigshospitalet, Denmark
- Rijnstate Hospital
- Sahlgrenska University Hospital
- Skane University Hospital
- Sorlandet Hospital HF
- Spital STS AG
- St. Antonius Hospital
- St. Olavs Hospital
- The Netherlands Cancer Institute
- Ullevaal University Hospital
- University Hospital of North Norway
- University Hospital, Akershus
- University Hospital, Basel, Switzerland
- University Hospital, Linkoeping
- Vestre Viken Hospital Trust
- Volda Hospital
- Zuyderland Medisch Centrum
- Ôrebro University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aalborg, Denmark , Amsterdam, Netherlands , Arnhem, Netherlands , Basel, Switzerland , Bergen, Norway , Bern, Switzerland , Breda, Netherlands , Chur, Switzerland , Copenhagen, Denmark , Drammen, Norway and 29 more locations